Switch to:
Abbott Laboratories (NYSE:ABT)
Cash from Financing
$-3,115 Mil (TTM As of Mar. 2014)

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Mar. 2014, Abbott Laboratories paid $2,192 Mil more to buy back shares than it received from issuing new shares. It received $1,213 Mil from issuing more debt. It paid $0 Mil more to buy back preferred shares than it received from issuing preferred shares. It spent $343 Mil paying cash dividends to shareholders. It received $170 Mil on other financial activities. In all, Abbott Laboratories spent $1,152 Mil on financial activities for the three months ended in Mar. 2014.


Definition

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Abbott Laboratories's Cash from Financing for the fiscal year that ended in Dec. 2013 is calculated as:

Cash from Financing(A: Dec. 2013 )
=Net Issuance of Stock+Net Issuance of Debt+Net Issuance of Preferred+Dividends+Other Financing
=-1605+1792+0+-882+-6001
=-6,696

Abbott Laboratories's Cash from Financing for the quarter that ended in Mar. 2014 is

Cash from Financing(Q: Mar. 2014 )
=Net Issuance of Stock+Net Issuance of Debt+Net Issuance of Preferred+Dividends+Other Financing
=-2192+1213+0+-343+170
=-1,152

Abbott Laboratories Cash Flow from Financing for the trailing twelve months (TTM) ended in Mar. 2014 was 465 (Jun. 2013 ) + -558.945 (Sep. 2013 ) + -1869.055 (Dec. 2013 ) + -1152 (Mar. 2014 ) = $-3,115 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

Cash from financing contains five items:

1. Net Issuance of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. If this number is positive, it means that the company has received more cash from issuing shares than it has paid to buy back shares. If this number is negative, it means that company has paid more cash to buy back shares than it has received for issuing shares.

Abbott Laboratories's net issuance of stock for the three months ended in Mar. 2014 was $-2,192 Mil. Abbott Laboratories paid $2,192 Mil more to buy back shares than it received from issuing new shares.

2. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Abbott Laboratories's net issuance of debt for the three months ended in Mar. 2014 was $1,213 Mil. Abbott Laboratories received $1,213 Mil from issuing more debt.

3. Net Issuance of Preferred:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Abbott Laboratories's net issuance of preferred for the three months ended in Mar. 2014 was $0 Mil. Abbott Laboratories paid $0 Mil more to buy back preferred shares than it received from issuing preferred shares.

4. Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Abbott Laboratories's cash flow for dividends for the three months ended in Mar. 2014 was $-343 Mil. Abbott Laboratories spent $343 Mil paying cash dividends to shareholders.

5. Other Financing:
Money spent or earned by company from other financial activities.

Abbott Laboratories's other financing for the three months ended in Mar. 2014 was $170 Mil. Abbott Laboratories received $170 Mil on other financial activities.


Related Terms

Cash Flow from Operations, Cash Flow from Investing, Net Issuance of Stock, Net Issuance of Debt, Dividends, Net Issuance of Preferred


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Abbott Laboratories Annual Data

Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
Net Issuance of Stock -345-1,079-252191-1,082-826-867-77-2,364-1,605
Net Issuance of Debt 8061735,651-544-1,2393,7342,122-3,9774,4131,792
Net Issuance of Preferred 0000000000
Dividends -1,600-1,686-1,777-1,959-2,174-2,414-2,671-2,938-3,183-882
Other Financing 7000001,0095093289691,329-6,001
Cash from Financing -438-2,5923,622-2,313-3,4861,002-1,088-6,023195-6,696

Abbott Laboratories Quarterly Data

Mar12Jun12Sep12Dec12Mar13Jun13Sep13Dec13Mar14Jun14
Net Issuance of Stock -988-734-1-641-925-290-351-39-2,192-1
Net Issuance of Debt 1,3451,298-1,9083,6792,248902374-1,7321,213-341
Net Issuance of Preferred 0000000000
Dividends -759-807-805-812-224-220-220-218-343-333
Other Financing 566359124279-5,83273-36212017056
Cash from Financing 165115-2,5912,505-4,733465-559-1,869-1,152-619
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide